Hims Hers Health Inc (HIMS) Stock Analysis
$HIMS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
Hims Hers Health (HIMS), a DRUG MANUFACTURERS - SPECIALTY & GENERIC company, has a market capitalization of about $6.31B.
Price
$28.07
Market cap
$6.31B
Dividend yield
—
About Hims Hers Health Inc
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San Francisco, California.
How StockWorthy values HIMS
StockWorthy forecasts Hims Hers Health Inc's revenue, operating profitability, reinvestment (capital expenditure, depreciation and working capital) and unlevered free cash flow, then discounts those cash flows using a normalized cost of capital built from HIMS's size, profitability and balance-sheet risk. Terminal growth is adjusted to reflect the company's mature growth profile rather than a fixed number. The model presents bear, base and bull scenarios, and every key assumption stays transparent and adjustable in the full StockWorthy analysis. Results are educational and not investment advice.
See HIMS's Fair Value
Create a free account to view Hims Hers Health Inc's base-case fair value, the bear–bull modeled range, and every assumption behind them. Free accounts include 5 stock valuations per month — plus Advanced DCF models, financial charts, dividends, and peer analysis.